Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

globenewswire.com - Zealand Pharma - Zealand Pharma to participate in the Goldman Sachs Global Healthcare Conference
Zealand Pharma to participate in the Goldman Sachs Global Healthcare Conference
GlobeNewswire

Press release – No. 12 / 2026 Zealand Pharma to participate in the Goldman Sachs Global Healthcare Conference Copenhagen, Denmark, June 2, 2026 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the…

rediff.com - Sohini Das - Indian Pharma Companies Boost US Specialty Drug Investment Amidst Generic Market Challenges
Indian Pharma Companies Boost US Specialty Drug Investment Amidst Generic Market Challenges
Rediff.com

Indian pharmaceutical companies are strategically pivoting their US market approach, deepening investments in high-value specialty drugs, complex therapies, and local manufacturing to counter pricing pressures and intensifying competition in…

newswire.ca - Duchesnay Pharmaceutical Group - Five years after its acquisition by senior management, Duchesnay Pharmaceutical Group continues to grow as one of Canada's few full-range pharma businesses
Five years after its acquisition by senior management, Duchesnay Pharmaceutical Group continues to grow as one of Canada's few full-range pharma businesses
CNW

BLAINVILLE, QC, June 2, 2026 /CNW/ - Duchesnay Pharmaceutical Group (DPG) is celebrating five years of sustained growth since its acquisition by senior management in 2021, a milestone that led to the formal creation of the Group. Since the buyout…

seekingalpha.com - Albert Anthony - Appian: Tech Platform With Margin And Cashflow Recovery Trends, Despite Q1 Net Loss (APPN)
Appian: Tech Platform With Margin And Cashflow Recovery Trends, Despite Q1 Net Loss (APPN)
Seeking Alpha

Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…

seekingalpha.com - Dulan Lokuwithana - UroGen settles with Teva over Jelmyto patent row (URGN:NASDAQ)
UroGen settles with Teva over Jelmyto patent row (URGN:NASDAQ)
Seeking Alpha

UroGen Pharma (URGN) announced on Tuesday that it reached a settlement and license agreement with Teva Pharmaceuticals (TEVA) to resolve a patent dispute over its cancer therapy Jelmyto. The dispute arose after the Israeli drugmaker sought to…

globenewswire.com - Santhera Pharmaceuticals Holding AG - Santhera Announces Orphan Drug and Priority Review Designations for AGAMREE (Vamorolone) in South Korea
Santhera Announces Orphan Drug and Priority Review Designations for AGAMREE (Vamorolone) in South Korea
GlobeNewswire

Pratteln, Switzerland, June 2, 2026 – Santhera Pharmaceuticals (SIX: SANN) today notes that AGAMREE has been granted Orphan Drug Designation (ODD) and Global Innovative Products on Fast Track (GIFT) designation by South Korea's Ministry of…

washingtonexaminer.com - Kaelan Deese - High-profile convicts lobby for rumored pardons tied to country's 250th birthday
High-profile convicts lobby for rumored pardons tied to country's 250th birthday
Washington Examiner

“The President is the final decider on all pardons or commutations,” the official added. Still, the mere possibility of looming pardons has already triggered sharp interest from figures such as Martin Shkreli, whose decision to raise…

zerohedge.com - Tyler Durden - Abivax Crashes Most On Record After Cancer Cases In Trial Data Spooks Wall Street
Abivax Crashes Most On Record After Cancer Cases In Trial Data Spooks Wall Street
Zero Hedge

French biotech Abivax suffered its largest intraday decline on record after reporting new data on its lead experimental inflammatory bowel disease drug, which showed cancer cases among patients in the clinical trial. The new data certainly point to…

siliconrepublic.com - Laura Varley - 10 companies actively recruiting for roles in future health
10 companies actively recruiting for roles in future health
Silicon Republic

If you are a professional looking for your next opportunity in the growing future health space, consider one of the following 10 companies. When it comes to careers in future health, there are an array of exciting opportunities for professionals…

news-medical.net - Building quality into drug development for safer, faster medicines
Building quality into drug development for safer, faster medicines
News-Medical

insights from industryAnil KaneExecutive Director, Global Head of Technical & Scientific AffairsPantheon, Thermo Fisher Scientific In this interview, News Medical-Life Sciences speaks with Anil Kane, pharmaceutical development expert at Thermo…

cnbc.com - Elsa Ohlen - Biotech takeover target Abivax sinks over 30% after bowel disease drug trial update
Biotech takeover target Abivax sinks over 30% after bowel disease drug trial update
CNBC

Shares of the stock tumbled as much as 32% Tuesday. Abivax' lead asset met its endpoints of demonstrating a clinically meaningful efficacy, but trial data also showed there were three cancer cases among patients taking the higher dose. Shares of…

newswire.ca - Pictor Reports Strong Commercial Momentum One Year After Launching U.S. Headquarters
Pictor Reports Strong Commercial Momentum One Year After Launching U.S. Headquarters
CNW

The targeted proteomic platform company marks its first anniversary in Carlsbad with four commercial partnerships, seven products, BSL-2 equipped lab, and growing adoption across human and animal health markets globally CARLSBAD, Calif., June 2…

thehindubusinessline.com - Alkem rolls out single-shot pre-filled syringes of semaglutide
Alkem rolls out single-shot pre-filled syringes of semaglutide
BusinessLine

Alkem Laboratories has brought in semaglutide in single-shot pre-filled syringes, in multiple dose strengths, starting at ₹350, the company said. The company had received the regulatory Drugs Controller General of India's approval for the…

fool.com - Motley Fool Transcribing - Nautilus (NAUT) Q1 2026 Earnings Transcript
Nautilus (NAUT) Q1 2026 Earnings Transcript
The Motley Fool

Tuesday, April 28, 2026 at 8:30 a.m. ET Chief Executive Officer — Sujal Patel Chief Scientist — Parag Mallick Chief Financial Officer — Anna Mowry Need a quote from a Motley Fool analyst? Email [email protected] Total Operating…

axios.com - Lucinda Shen - Cyera's $12b valuation, Brian Armstrong's new, NewLimit, and H&F's $1.8b Hyve buy
Cyera's $12b valuation, Brian Armstrong's new, NewLimit, and H&F's $1.8b Hyve buy
Axios

• Cyera, a NYC-based data security company, raised a $300m round at a $12b valuation. Evolution Equity Partners led, joined by Georgian, Greenoaks, Lightspeed Venture Partners, Sequoia Capital, Sapphire Ventures, Redpoint Ventures…

Receive a Daily briefing on Pharma Industry News

Get Started